SlideShare a Scribd company logo
ATN
OVMC LANDMARK TRIALS SERIES
Palevsky PM, et al. "Intensity of renal support in
critically ill patients with acute kidney injury". The New
England Journal of Medicine. 2008. 359(1):7-20.
Acute Renal Failure Trial Network Study (ATN)
BACKGROUND
SOME FACTS:
๏‚ก Acute tubular necrosis (ATN) is associated with a
mortality of >50% in critically ill patients
๏‚ก ATN involves the death of tubular epithelial cells of
the renal tubules of the kidneys. Common causes
include low BP and use of nephrotoxic drugs
PRIOR TO TRIAL:
๏‚ก Prior to the ATN trial, the intensity of renal
replacement therapy (RRT) has not been well
established.
๏‚ก Many single center trials showed that intensive RRT
programs led improved mortality
CLINICAL QUESTION
๏‚ก In critically ill patients with acute
tubular necrosis, does more
intensive renal replacement
therapy decrease the risk of
death at 60 days compared to
conventional less-intensive
renal replacement therapy?
Photo Credit: Pathology Department of James Cook University
DESIGN
๏‚ก Analysis: Intention-to-treat
๏‚ก Multicenter, open-label, parallel-group, randomized, controlled trial
๏‚ก N=1,124 patients with critical illness and ATN
๏‚ก Intensive renal replacement therapy (n=563)
๏‚ก Conventional low-intensity renal replacement therapy (n=561)
๏‚ก Setting: 31 centers in the United States
๏‚ก Enrollment: 2003-2007
๏‚ก Follow-up: 60 days
๏‚ก Primary outcome: All-cause mortality at 60 days
POPULATION
Inclusion Criteria
๏‚ก Age โ‰ฅ18 years
๏‚ก Admitted to ICU
๏‚ก Acute tubular necrosis, defined by:
๏‚ก Clinically apparent ischemia or nephrotoxic injury
and
๏‚ก One or more of oliguria (average urine output <
20 ml/hr for >24 hours), or increased serum
creatinine >2 in men or >1.5 in women
๏‚ก Failure of one or more non-renal organs (SOFA
score โ‰ฅ2) or sepsis
Exclusion Criteria
๏‚ก Elevated baseline serum creatinine >2 mg/dl
for men and >1.5 mg/dl for women)
๏‚ก Etiology of AKI other than ATN
๏‚ก Hemodialysis already given
๏‚ก Previous renal transplant
๏‚ก Pregnancy
๏‚ก Prisoner
๏‚ก Weight >128.5 kg
๏‚ก Patient unlikely to survive 28 days
INTERVENTIONS
๏‚ก Randomization:
๏‚ก Intensive RRT
๏‚ก Conventional less intensive RRT
๏‚ก Sequential Organ Failure Assessment (SOFA) Score determined intermittent versus continuous therapy. There
were different modalities that were used, but study only examined treatment intensity
๏‚ก Intensive renal replacement therapy:
๏‚ก Intermittent hemodialysis or sustained low-efficiency dialysis: 6 treatments per week
๏‚ก Continuous venovenous hemodiafiltration (CVVHDF): Prescribed total effluent flow rate of 35 ml/kg/hour
๏‚ก Conventional renal replacement therapy:
๏‚ก Intermittent hemodialysis or sustained low-efficiency dialysis: 3 treatments per week
๏‚ก Continuous venovenous hemodiafiltration (CVVHDF): Prescribed total effluent flow rate of 20 ml/kg/hour
CRITICISMS
๏‚ก Timing of RRT initiation was not standardized
๏‚ก Many patients in study had dynamically changing disease severity, BUT a dynamic dosing regimen
was not used
๏‚ก Possible biased outcomes due to prolonged ICU stay, differences in fluid balance, high rate of
treatment with CRRT before randomization
๏‚ก It is unclear why the renal recovery rate was so low
๏‚ก Generalizability limited because:
๏‚ก Men were overrepresented in the study (25% from VA centers)
๏‚ก Excluded patients with baseline advanced CKD
BOTTOM LINE
In critically ill patients with acute tubular
necrosis, more intensive renal
replacement therapy DOES NOT
improve all-cause mortality at 60 days
compared to conventional less-intensive
therapy.
Intensive RRT DID NOT improve renal
function or nonrenal organ dysfunction,
although it was associated with more
frequent hypotensive episodes.
DISCUSSION QUESTIONS
๏‚ก What did the ATN show in terms of intensive RRT and renal function?
๏‚ก What type of patients were studied in the ATN trial?
๏‚ก Possible controversy: how should unstable patients with acute kidney injury be treated?
DISCUSSION QUESTIONS/ANSWERS
๏‚ก What did the ATN show in terms of intensive RRT and renal function?
๏‚ก ANSWER: RRT did not improve renal function or nonrenal organ dysfunction, although it was
associated with more frequent hypotensive episodes.
๏‚ก What type of patients were studied in the ATN trial?
๏‚ก ANSWER: ICU patients with apparent nephrotoxic injury and evidence of kidney injury
๏‚ก Defined as oliguria (average urine output < 20 ml/hr for >24 hours), OR increased serum
creatinine >2 in men or >1.5 in women
MKSAP NEPHROLOGY QUESTION #32
A 47-year-old man is admitted to the medical ICU with
severe sepsis, multi-lobar pneumonia, and acute
respiratory distress syndrome. He developed oliguric
acute kidney injury on hospital day 3; he has produced
only 240 mL of urine over the past 24 hours despite
adequate intravenous hydration. He is mechanically
ventilated and requires 80% FIO2. Medical history is
unremarkable, and current medications are
piperacillin/tazobactam, vancomycin, norepinephrine,
vasopressin and propofol infusions, and a proton pump
inhibitor.
On physical examination the patient is intubated and
sedated. Temperature is 38.5 ยฐC (101.3 ยฐF), blood pressure
is 95/60 mm Hg, and pulse rate is 130/min. Estimated
central venous pressure is 14 cm H2O. There is no rash.
Generalized anasarca is noted. Examination of the chest
reveals coarse breath sounds and inspiratory crackles
throughout both lungs.
(ADAPTED from MKSAP 17)
Which of the following is the most appropriate treatment
for this patient's kidney failure?
A. Initiate continuous renal replacement therapy
B. Initiate intermittent hemodialysis
C. Initiate slow continuous ultrafiltration
D. Start laxis IV
ANSWER UP FOR DISCUSSION
Educational Objective:
Treat acute kidney injury with continuous renal
replacement therapy.
Key Point:
- Continuous renal replacement therapy is
preferred for critically ill, unstable patients
with acute kidney injury because it provides a
slower rate of solute and fluid removal per
unit of time, resulting in better hemodynamic
tolerance.
- Tolwani A. Continuous renal replacement
therapy for AKI. N Engl J Med. 2012 Dec
27;367(26):2505-14.
ANSWER
Which of the following is the most
appropriate treatment for this patient's
kidney failure?
A. Initiate continuous renal replacement
therapy
B. Initiate intermittent hemodialysis
C. Initiate slow continuous ultrafiltration
D. Start laxis IV

More Related Content

What's hot

STOPAH
STOPAHSTOPAH
STOPAH
Isabella Nga Lai
ย 
CORTICUS
CORTICUSCORTICUS
CORTICUS
Isabella Nga Lai
ย 
SALT-E 3
SALT-E 3SALT-E 3
SALT-E 3
Isabella Nga Lai
ย 
SALT-E 4
SALT-E 4SALT-E 4
SALT-E 4
Isabella Nga Lai
ย 
BEST OF ESC 2020
BEST OF ESC 2020BEST OF ESC 2020
BEST OF ESC 2020
Praveen Nagula
ย 
Journal club 26- 5-2017
Journal club 26- 5-2017Journal club 26- 5-2017
Journal club 26- 5-2017
Amit Verma
ย 
Riociguat for the treatment of pah
Riociguat for the treatment of pahRiociguat for the treatment of pah
Riociguat for the treatment of pah
Vishwanath Hesarur
ย 
SALT-E 2
SALT-E 2SALT-E 2
SALT-E 2
Isabella Nga Lai
ย 
Recovery trial
Recovery trialRecovery trial
Recovery trial
Himanshu Rana
ย 
Effect of pci on long term survival in patients
Effect of pci on long term survival in patientsEffect of pci on long term survival in patients
Effect of pci on long term survival in patients
Monish Hassan
ย 
Courage TRIAL 2007
Courage TRIAL 2007Courage TRIAL 2007
Courage TRIAL 2007
Valmiki Seecheran
ย 
Intravenous thrombolysis for acute ischemic stroke 2014
Intravenous thrombolysis for acute ischemic stroke 2014Intravenous thrombolysis for acute ischemic stroke 2014
Intravenous thrombolysis for acute ischemic stroke 2014
Javier Pacheco Paternina
ย 
Update in vte 2019 focus on current use of doac
Update in vte 2019  focus on current use of doacUpdate in vte 2019  focus on current use of doac
Update in vte 2019 focus on current use of doac
Kaipol Takpradit
ย 
Stroke thrombolysis
Stroke thrombolysisStroke thrombolysis
Stroke thrombolysis
Iain McNeill
ย 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Test
ahvc0858
ย 
Evolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic StrokeEvolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic Stroke
Pramod Krishnan
ย 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
cardiositeindia
ย 
Sacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart diseaseSacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart disease
pankaj bhosale
ย 
2014 stable-ischemic-heart-disease-guideline-slide set
2014 stable-ischemic-heart-disease-guideline-slide set2014 stable-ischemic-heart-disease-guideline-slide set
2014 stable-ischemic-heart-disease-guideline-slide set
sajjad safi
ย 
Care For Vent Pt
Care For Vent PtCare For Vent Pt
Care For Vent Pt
gueste504a59
ย 

What's hot (20)

STOPAH
STOPAHSTOPAH
STOPAH
ย 
CORTICUS
CORTICUSCORTICUS
CORTICUS
ย 
SALT-E 3
SALT-E 3SALT-E 3
SALT-E 3
ย 
SALT-E 4
SALT-E 4SALT-E 4
SALT-E 4
ย 
BEST OF ESC 2020
BEST OF ESC 2020BEST OF ESC 2020
BEST OF ESC 2020
ย 
Journal club 26- 5-2017
Journal club 26- 5-2017Journal club 26- 5-2017
Journal club 26- 5-2017
ย 
Riociguat for the treatment of pah
Riociguat for the treatment of pahRiociguat for the treatment of pah
Riociguat for the treatment of pah
ย 
SALT-E 2
SALT-E 2SALT-E 2
SALT-E 2
ย 
Recovery trial
Recovery trialRecovery trial
Recovery trial
ย 
Effect of pci on long term survival in patients
Effect of pci on long term survival in patientsEffect of pci on long term survival in patients
Effect of pci on long term survival in patients
ย 
Courage TRIAL 2007
Courage TRIAL 2007Courage TRIAL 2007
Courage TRIAL 2007
ย 
Intravenous thrombolysis for acute ischemic stroke 2014
Intravenous thrombolysis for acute ischemic stroke 2014Intravenous thrombolysis for acute ischemic stroke 2014
Intravenous thrombolysis for acute ischemic stroke 2014
ย 
Update in vte 2019 focus on current use of doac
Update in vte 2019  focus on current use of doacUpdate in vte 2019  focus on current use of doac
Update in vte 2019 focus on current use of doac
ย 
Stroke thrombolysis
Stroke thrombolysisStroke thrombolysis
Stroke thrombolysis
ย 
CT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress TestCT Coronary Angiogram VS Cardiac Stress Test
CT Coronary Angiogram VS Cardiac Stress Test
ย 
Evolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic StrokeEvolving landscape in the management of Acute Ischemic Stroke
Evolving landscape in the management of Acute Ischemic Stroke
ย 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
ย 
Sacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart diseaseSacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart disease
ย 
2014 stable-ischemic-heart-disease-guideline-slide set
2014 stable-ischemic-heart-disease-guideline-slide set2014 stable-ischemic-heart-disease-guideline-slide set
2014 stable-ischemic-heart-disease-guideline-slide set
ย 
Care For Vent Pt
Care For Vent PtCare For Vent Pt
Care For Vent Pt
ย 

Similar to ATN

Approach to cardio renal syndrome
Approach to cardio renal syndromeApproach to cardio renal syndrome
Approach to cardio renal syndrome
ajayyadav753
ย 
AKIforResidentsInternalMedicine2022.pptx
AKIforResidentsInternalMedicine2022.pptxAKIforResidentsInternalMedicine2022.pptx
AKIforResidentsInternalMedicine2022.pptx
hcahoustonim
ย 
Prevention of AKI
Prevention of AKIPrevention of AKI
Prevention of AKI
DrAnkitPurohit
ย 
Acute Kidney Dysfunction
Acute Kidney DysfunctionAcute Kidney Dysfunction
Acute Kidney Dysfunction
Andrew Ferguson
ย 
Acute kidney injury: Perioperative implications
Acute kidney injury: Perioperative implicationsAcute kidney injury: Perioperative implications
Acute kidney injury: Perioperative implications
Abhijit Nair
ย 
02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
Dang Thanh Tuan
ย 
02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
guest2379201
ย 
Renal lecture
Renal lecture Renal lecture
Renal lecture
Susan Schlueter
ย 
Continuous renal replacement therapy in AKI
Continuous renal replacement therapy in AKIContinuous renal replacement therapy in AKI
Continuous renal replacement therapy in AKI
Abduzhappar Gaipov
ย 
Acute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementAcute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic management
drriyas03
ย 
29 amory renal failure
29 amory   renal failure29 amory   renal failure
29 amory renal failure
Dang Thanh Tuan
ย 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI
Manish Singla
ย 
ANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANT
ANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANTANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANT
ANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANT
drvipinKumarGoyal
ย 
Acute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerAcute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with Cancer
Christos Argyropoulos
ย 
contrast induced nephropathy, CIN
contrast induced nephropathy, CINcontrast induced nephropathy, CIN
contrast induced nephropathy, CIN
Avisek Dutta
ย 
Hrs ashraf omar
Hrs ashraf omarHrs ashraf omar
Hrs ashraf omar
FAARRAG
ย 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
guest2379201
ย 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
Dang Thanh Tuan
ย 
pancreatitis anoop k r
pancreatitis anoop k rpancreatitis anoop k r
pancreatitis anoop k r
anoop k r
ย 
Aki icu
Aki icuAki icu
Aki icu
Muhamed Al Rohani
ย 

Similar to ATN (20)

Approach to cardio renal syndrome
Approach to cardio renal syndromeApproach to cardio renal syndrome
Approach to cardio renal syndrome
ย 
AKIforResidentsInternalMedicine2022.pptx
AKIforResidentsInternalMedicine2022.pptxAKIforResidentsInternalMedicine2022.pptx
AKIforResidentsInternalMedicine2022.pptx
ย 
Prevention of AKI
Prevention of AKIPrevention of AKI
Prevention of AKI
ย 
Acute Kidney Dysfunction
Acute Kidney DysfunctionAcute Kidney Dysfunction
Acute Kidney Dysfunction
ย 
Acute kidney injury: Perioperative implications
Acute kidney injury: Perioperative implicationsAcute kidney injury: Perioperative implications
Acute kidney injury: Perioperative implications
ย 
02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
ย 
02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
ย 
Renal lecture
Renal lecture Renal lecture
Renal lecture
ย 
Continuous renal replacement therapy in AKI
Continuous renal replacement therapy in AKIContinuous renal replacement therapy in AKI
Continuous renal replacement therapy in AKI
ย 
Acute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementAcute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic management
ย 
29 amory renal failure
29 amory   renal failure29 amory   renal failure
29 amory renal failure
ย 
Contrast Nephropathy AKI
Contrast Nephropathy AKI  Contrast Nephropathy AKI
Contrast Nephropathy AKI
ย 
ANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANT
ANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANTANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANT
ANESTHESIA CONSIDERATIONS FOR KIDNEY TRANSPLANT
ย 
Acute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with CancerAcute Kidney Injury in Patients with Cancer
Acute Kidney Injury in Patients with Cancer
ย 
contrast induced nephropathy, CIN
contrast induced nephropathy, CINcontrast induced nephropathy, CIN
contrast induced nephropathy, CIN
ย 
Hrs ashraf omar
Hrs ashraf omarHrs ashraf omar
Hrs ashraf omar
ย 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
ย 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
ย 
pancreatitis anoop k r
pancreatitis anoop k rpancreatitis anoop k r
pancreatitis anoop k r
ย 
Aki icu
Aki icuAki icu
Aki icu
ย 

More from Isabella Nga Lai

UKPDS
UKPDSUKPDS
DCCT
DCCTDCCT
ACCORD
ACCORDACCORD
ACCORD
Isabella Nga Lai
ย 
RABBIT 2
RABBIT 2RABBIT 2
RABBIT 2
Isabella Nga Lai
ย 
Vancomycin vs Metronidazole in C.Diff
Vancomycin vs Metronidazole in C.DiffVancomycin vs Metronidazole in C.Diff
Vancomycin vs Metronidazole in C.Diff
Isabella Nga Lai
ย 
SONIC
SONICSONIC
Fidaxomicin in cdiff
Fidaxomicin in cdiffFidaxomicin in cdiff
Fidaxomicin in cdiff
Isabella Nga Lai
ย 
COLONPREV
COLONPREVCOLONPREV
COLONPREV
Isabella Nga Lai
ย 
SALT-E 6
SALT-E 6SALT-E 6
SALT-E 6
Isabella Nga Lai
ย 
SALT-E 5
SALT-E 5SALT-E 5
SALT-E 5
Isabella Nga Lai
ย 
GI Bleed
GI BleedGI Bleed
GI Bleed
Isabella Nga Lai
ย 

More from Isabella Nga Lai (11)

UKPDS
UKPDSUKPDS
UKPDS
ย 
DCCT
DCCTDCCT
DCCT
ย 
ACCORD
ACCORDACCORD
ACCORD
ย 
RABBIT 2
RABBIT 2RABBIT 2
RABBIT 2
ย 
Vancomycin vs Metronidazole in C.Diff
Vancomycin vs Metronidazole in C.DiffVancomycin vs Metronidazole in C.Diff
Vancomycin vs Metronidazole in C.Diff
ย 
SONIC
SONICSONIC
SONIC
ย 
Fidaxomicin in cdiff
Fidaxomicin in cdiffFidaxomicin in cdiff
Fidaxomicin in cdiff
ย 
COLONPREV
COLONPREVCOLONPREV
COLONPREV
ย 
SALT-E 6
SALT-E 6SALT-E 6
SALT-E 6
ย 
SALT-E 5
SALT-E 5SALT-E 5
SALT-E 5
ย 
GI Bleed
GI BleedGI Bleed
GI Bleed
ย 

Recently uploaded

Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
EduSkills OECD
ย 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
imrankhan141184
ย 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
iammrhaywood
ย 
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) Curriculum
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) CurriculumPhilippine Edukasyong Pantahanan at Pangkabuhayan (EPP) Curriculum
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) Curriculum
MJDuyan
ย 
Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...
Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...
Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...
Nguyen Thanh Tu Collection
ย 
Haunted Houses by H W Longfellow for class 10
Haunted Houses by H W Longfellow for class 10Haunted Houses by H W Longfellow for class 10
Haunted Houses by H W Longfellow for class 10
nitinpv4ai
ย 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Henry Hollis
ย 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
JomonJoseph58
ย 
Bonku-Babus-Friend by Sathyajith Ray (9)
Bonku-Babus-Friend by Sathyajith Ray  (9)Bonku-Babus-Friend by Sathyajith Ray  (9)
Bonku-Babus-Friend by Sathyajith Ray (9)
nitinpv4ai
ย 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
melliereed
ย 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
PsychoTech Services
ย 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
danielkiash986
ย 
SWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptxSWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptx
zuzanka
ย 
How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17
Celine George
ย 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
TechSoup
ย 
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
National Information Standards Organization (NISO)
ย 
Standardized tool for Intelligence test.
Standardized tool for Intelligence test.Standardized tool for Intelligence test.
Standardized tool for Intelligence test.
deepaannamalai16
ย 
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
indexPub
ย 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
giancarloi8888
ย 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
HajraNaeem15
ย 

Recently uploaded (20)

Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
ย 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
ย 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
ย 
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) Curriculum
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) CurriculumPhilippine Edukasyong Pantahanan at Pangkabuhayan (EPP) Curriculum
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) Curriculum
ย 
Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...
Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...
Bร€I TแบฌP Dแบ Y THรŠM TIแบพNG ANH LแปšP 7 Cแบข Nฤ‚M FRIENDS PLUS SรCH CHร‚N TRแปœI SรNG Tแบ O ...
ย 
Haunted Houses by H W Longfellow for class 10
Haunted Houses by H W Longfellow for class 10Haunted Houses by H W Longfellow for class 10
Haunted Houses by H W Longfellow for class 10
ย 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
ย 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
ย 
Bonku-Babus-Friend by Sathyajith Ray (9)
Bonku-Babus-Friend by Sathyajith Ray  (9)Bonku-Babus-Friend by Sathyajith Ray  (9)
Bonku-Babus-Friend by Sathyajith Ray (9)
ย 
Nutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour TrainingNutrition Inc FY 2024, 4 - Hour Training
Nutrition Inc FY 2024, 4 - Hour Training
ย 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
ย 
Pharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brubPharmaceutics Pharmaceuticals best of brub
Pharmaceutics Pharmaceuticals best of brub
ย 
SWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptxSWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptx
ย 
How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17
ย 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
ย 
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
Jemison, MacLaughlin, and Majumder "Broadening Pathways for Editors and Authors"
ย 
Standardized tool for Intelligence test.
Standardized tool for Intelligence test.Standardized tool for Intelligence test.
Standardized tool for Intelligence test.
ย 
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...
ย 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
ย 
How to deliver Powerpoint Presentations.pptx
How to deliver Powerpoint  Presentations.pptxHow to deliver Powerpoint  Presentations.pptx
How to deliver Powerpoint Presentations.pptx
ย 

ATN

  • 1. ATN OVMC LANDMARK TRIALS SERIES Palevsky PM, et al. "Intensity of renal support in critically ill patients with acute kidney injury". The New England Journal of Medicine. 2008. 359(1):7-20.
  • 2. Acute Renal Failure Trial Network Study (ATN)
  • 3. BACKGROUND SOME FACTS: ๏‚ก Acute tubular necrosis (ATN) is associated with a mortality of >50% in critically ill patients ๏‚ก ATN involves the death of tubular epithelial cells of the renal tubules of the kidneys. Common causes include low BP and use of nephrotoxic drugs PRIOR TO TRIAL: ๏‚ก Prior to the ATN trial, the intensity of renal replacement therapy (RRT) has not been well established. ๏‚ก Many single center trials showed that intensive RRT programs led improved mortality
  • 4. CLINICAL QUESTION ๏‚ก In critically ill patients with acute tubular necrosis, does more intensive renal replacement therapy decrease the risk of death at 60 days compared to conventional less-intensive renal replacement therapy? Photo Credit: Pathology Department of James Cook University
  • 5. DESIGN ๏‚ก Analysis: Intention-to-treat ๏‚ก Multicenter, open-label, parallel-group, randomized, controlled trial ๏‚ก N=1,124 patients with critical illness and ATN ๏‚ก Intensive renal replacement therapy (n=563) ๏‚ก Conventional low-intensity renal replacement therapy (n=561) ๏‚ก Setting: 31 centers in the United States ๏‚ก Enrollment: 2003-2007 ๏‚ก Follow-up: 60 days ๏‚ก Primary outcome: All-cause mortality at 60 days
  • 6. POPULATION Inclusion Criteria ๏‚ก Age โ‰ฅ18 years ๏‚ก Admitted to ICU ๏‚ก Acute tubular necrosis, defined by: ๏‚ก Clinically apparent ischemia or nephrotoxic injury and ๏‚ก One or more of oliguria (average urine output < 20 ml/hr for >24 hours), or increased serum creatinine >2 in men or >1.5 in women ๏‚ก Failure of one or more non-renal organs (SOFA score โ‰ฅ2) or sepsis Exclusion Criteria ๏‚ก Elevated baseline serum creatinine >2 mg/dl for men and >1.5 mg/dl for women) ๏‚ก Etiology of AKI other than ATN ๏‚ก Hemodialysis already given ๏‚ก Previous renal transplant ๏‚ก Pregnancy ๏‚ก Prisoner ๏‚ก Weight >128.5 kg ๏‚ก Patient unlikely to survive 28 days
  • 7. INTERVENTIONS ๏‚ก Randomization: ๏‚ก Intensive RRT ๏‚ก Conventional less intensive RRT ๏‚ก Sequential Organ Failure Assessment (SOFA) Score determined intermittent versus continuous therapy. There were different modalities that were used, but study only examined treatment intensity ๏‚ก Intensive renal replacement therapy: ๏‚ก Intermittent hemodialysis or sustained low-efficiency dialysis: 6 treatments per week ๏‚ก Continuous venovenous hemodiafiltration (CVVHDF): Prescribed total effluent flow rate of 35 ml/kg/hour ๏‚ก Conventional renal replacement therapy: ๏‚ก Intermittent hemodialysis or sustained low-efficiency dialysis: 3 treatments per week ๏‚ก Continuous venovenous hemodiafiltration (CVVHDF): Prescribed total effluent flow rate of 20 ml/kg/hour
  • 8. CRITICISMS ๏‚ก Timing of RRT initiation was not standardized ๏‚ก Many patients in study had dynamically changing disease severity, BUT a dynamic dosing regimen was not used ๏‚ก Possible biased outcomes due to prolonged ICU stay, differences in fluid balance, high rate of treatment with CRRT before randomization ๏‚ก It is unclear why the renal recovery rate was so low ๏‚ก Generalizability limited because: ๏‚ก Men were overrepresented in the study (25% from VA centers) ๏‚ก Excluded patients with baseline advanced CKD
  • 9. BOTTOM LINE In critically ill patients with acute tubular necrosis, more intensive renal replacement therapy DOES NOT improve all-cause mortality at 60 days compared to conventional less-intensive therapy. Intensive RRT DID NOT improve renal function or nonrenal organ dysfunction, although it was associated with more frequent hypotensive episodes.
  • 10. DISCUSSION QUESTIONS ๏‚ก What did the ATN show in terms of intensive RRT and renal function? ๏‚ก What type of patients were studied in the ATN trial? ๏‚ก Possible controversy: how should unstable patients with acute kidney injury be treated?
  • 11. DISCUSSION QUESTIONS/ANSWERS ๏‚ก What did the ATN show in terms of intensive RRT and renal function? ๏‚ก ANSWER: RRT did not improve renal function or nonrenal organ dysfunction, although it was associated with more frequent hypotensive episodes. ๏‚ก What type of patients were studied in the ATN trial? ๏‚ก ANSWER: ICU patients with apparent nephrotoxic injury and evidence of kidney injury ๏‚ก Defined as oliguria (average urine output < 20 ml/hr for >24 hours), OR increased serum creatinine >2 in men or >1.5 in women
  • 12. MKSAP NEPHROLOGY QUESTION #32 A 47-year-old man is admitted to the medical ICU with severe sepsis, multi-lobar pneumonia, and acute respiratory distress syndrome. He developed oliguric acute kidney injury on hospital day 3; he has produced only 240 mL of urine over the past 24 hours despite adequate intravenous hydration. He is mechanically ventilated and requires 80% FIO2. Medical history is unremarkable, and current medications are piperacillin/tazobactam, vancomycin, norepinephrine, vasopressin and propofol infusions, and a proton pump inhibitor. On physical examination the patient is intubated and sedated. Temperature is 38.5 ยฐC (101.3 ยฐF), blood pressure is 95/60 mm Hg, and pulse rate is 130/min. Estimated central venous pressure is 14 cm H2O. There is no rash. Generalized anasarca is noted. Examination of the chest reveals coarse breath sounds and inspiratory crackles throughout both lungs. (ADAPTED from MKSAP 17) Which of the following is the most appropriate treatment for this patient's kidney failure? A. Initiate continuous renal replacement therapy B. Initiate intermittent hemodialysis C. Initiate slow continuous ultrafiltration D. Start laxis IV
  • 13. ANSWER UP FOR DISCUSSION Educational Objective: Treat acute kidney injury with continuous renal replacement therapy. Key Point: - Continuous renal replacement therapy is preferred for critically ill, unstable patients with acute kidney injury because it provides a slower rate of solute and fluid removal per unit of time, resulting in better hemodynamic tolerance. - Tolwani A. Continuous renal replacement therapy for AKI. N Engl J Med. 2012 Dec 27;367(26):2505-14. ANSWER Which of the following is the most appropriate treatment for this patient's kidney failure? A. Initiate continuous renal replacement therapy B. Initiate intermittent hemodialysis C. Initiate slow continuous ultrafiltration D. Start laxis IV